nodes	percent_of_prediction	percent_of_DWPC	metapath
Etravirine—ABCB4—bile duct—pancreatic cancer	0.0822	0.485	CbGeAlD
Etravirine—CYP2C19—Tamoxifen—pancreatic cancer	0.0663	0.118	CbGbCtD
Etravirine—ABCB4—bile—pancreatic cancer	0.0631	0.373	CbGeAlD
Etravirine—CYP2C9—Tamoxifen—pancreatic cancer	0.0551	0.0977	CbGbCtD
Etravirine—ABCB1—Tamoxifen—pancreatic cancer	0.0535	0.0948	CbGbCtD
Etravirine—ABCB1—Gemcitabine—pancreatic cancer	0.0461	0.0817	CbGbCtD
Etravirine—ABCB1—Erlotinib—pancreatic cancer	0.0455	0.0806	CbGbCtD
Etravirine—ABCB1—Irinotecan—pancreatic cancer	0.0411	0.0728	CbGbCtD
Etravirine—CYP2C9—Fluorouracil—pancreatic cancer	0.0406	0.072	CbGbCtD
Etravirine—CYP3A4—Tamoxifen—pancreatic cancer	0.032	0.0568	CbGbCtD
Etravirine—ABCB1—Docetaxel—pancreatic cancer	0.0301	0.0534	CbGbCtD
Etravirine—ABCB1—Sunitinib—pancreatic cancer	0.03	0.0531	CbGbCtD
Etravirine—CYP3A4—Erlotinib—pancreatic cancer	0.0272	0.0483	CbGbCtD
Etravirine—CYP3A4—Irinotecan—pancreatic cancer	0.0246	0.0436	CbGbCtD
Etravirine—ABCB1—Doxorubicin—pancreatic cancer	0.0224	0.0398	CbGbCtD
Etravirine—CYP3A4—Docetaxel—pancreatic cancer	0.018	0.032	CbGbCtD
Etravirine—CYP3A4—Sunitinib—pancreatic cancer	0.018	0.0318	CbGbCtD
Etravirine—ABCB4—gall bladder—pancreatic cancer	0.0175	0.104	CbGeAlD
Etravirine—CYP3A4—Doxorubicin—pancreatic cancer	0.0134	0.0238	CbGbCtD
Etravirine—CYP2C19—digestive system—pancreatic cancer	0.00163	0.00961	CbGeAlD
Etravirine—CYP2C9—digestive system—pancreatic cancer	0.00126	0.00745	CbGeAlD
Etravirine—ABCB1—islet of Langerhans—pancreatic cancer	0.00113	0.0067	CbGeAlD
Etravirine—CYP3A4—digestive system—pancreatic cancer	0.000962	0.00568	CbGeAlD
Etravirine—ABCB1—pancreas—pancreatic cancer	0.000798	0.00471	CbGeAlD
Etravirine—ABCB1—digestive system—pancreatic cancer	0.000681	0.00402	CbGeAlD
Etravirine—Rash—Erlotinib—pancreatic cancer	0.000335	0.00126	CcSEcCtD
Etravirine—Dermatitis—Erlotinib—pancreatic cancer	0.000335	0.00126	CcSEcCtD
Etravirine—Angiopathy—Docetaxel—pancreatic cancer	0.000335	0.00126	CcSEcCtD
Etravirine—Insomnia—Gemcitabine—pancreatic cancer	0.000334	0.00125	CcSEcCtD
Etravirine—Immune system disorder—Docetaxel—pancreatic cancer	0.000333	0.00125	CcSEcCtD
Etravirine—Headache—Erlotinib—pancreatic cancer	0.000333	0.00125	CcSEcCtD
Etravirine—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000333	0.00125	CcSEcCtD
Etravirine—Paraesthesia—Gemcitabine—pancreatic cancer	0.000332	0.00124	CcSEcCtD
Etravirine—Asthenia—Sunitinib—pancreatic cancer	0.00033	0.00124	CcSEcCtD
Etravirine—Dry skin—Epirubicin—pancreatic cancer	0.00033	0.00124	CcSEcCtD
Etravirine—Decreased appetite—Irinotecan—pancreatic cancer	0.00033	0.00124	CcSEcCtD
Etravirine—Insomnia—Fluorouracil—pancreatic cancer	0.000329	0.00123	CcSEcCtD
Etravirine—Somnolence—Gemcitabine—pancreatic cancer	0.000328	0.00123	CcSEcCtD
Etravirine—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000327	0.00123	CcSEcCtD
Etravirine—Fatigue—Irinotecan—pancreatic cancer	0.000327	0.00123	CcSEcCtD
Etravirine—Paraesthesia—Fluorouracil—pancreatic cancer	0.000326	0.00122	CcSEcCtD
Etravirine—Breast disorder—Epirubicin—pancreatic cancer	0.000325	0.00122	CcSEcCtD
Etravirine—Pain—Irinotecan—pancreatic cancer	0.000324	0.00122	CcSEcCtD
Etravirine—Constipation—Irinotecan—pancreatic cancer	0.000324	0.00122	CcSEcCtD
Etravirine—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.000324	0.00121	CcSEcCtD
Etravirine—Mental disorder—Docetaxel—pancreatic cancer	0.000323	0.00121	CcSEcCtD
Etravirine—Somnolence—Fluorouracil—pancreatic cancer	0.000323	0.00121	CcSEcCtD
Etravirine—Malnutrition—Docetaxel—pancreatic cancer	0.000321	0.0012	CcSEcCtD
Etravirine—Decreased appetite—Gemcitabine—pancreatic cancer	0.000321	0.0012	CcSEcCtD
Etravirine—Nausea—Tamoxifen—pancreatic cancer	0.000319	0.0012	CcSEcCtD
Etravirine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000319	0.0012	CcSEcCtD
Etravirine—Fatigue—Gemcitabine—pancreatic cancer	0.000318	0.00119	CcSEcCtD
Etravirine—Gastritis—Epirubicin—pancreatic cancer	0.000318	0.00119	CcSEcCtD
Etravirine—Pain—Gemcitabine—pancreatic cancer	0.000316	0.00118	CcSEcCtD
Etravirine—Constipation—Gemcitabine—pancreatic cancer	0.000316	0.00118	CcSEcCtD
Etravirine—Nausea—Erlotinib—pancreatic cancer	0.000316	0.00118	CcSEcCtD
Etravirine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000316	0.00118	CcSEcCtD
Etravirine—Diarrhoea—Sunitinib—pancreatic cancer	0.000315	0.00118	CcSEcCtD
Etravirine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000314	0.00118	CcSEcCtD
Etravirine—Abdominal distension—Epirubicin—pancreatic cancer	0.000313	0.00117	CcSEcCtD
Etravirine—Feeling abnormal—Irinotecan—pancreatic cancer	0.000313	0.00117	CcSEcCtD
Etravirine—Pain—Fluorouracil—pancreatic cancer	0.000311	0.00116	CcSEcCtD
Etravirine—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00031	0.00116	CcSEcCtD
Etravirine—Eosinophilia—Epirubicin—pancreatic cancer	0.000308	0.00115	CcSEcCtD
Etravirine—Dry skin—Doxorubicin—pancreatic cancer	0.000305	0.00114	CcSEcCtD
Etravirine—Pancreatitis—Epirubicin—pancreatic cancer	0.000305	0.00114	CcSEcCtD
Etravirine—Dizziness—Sunitinib—pancreatic cancer	0.000304	0.00114	CcSEcCtD
Etravirine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000304	0.00114	CcSEcCtD
Etravirine—Angina pectoris—Epirubicin—pancreatic cancer	0.000303	0.00114	CcSEcCtD
Etravirine—Breast disorder—Doxorubicin—pancreatic cancer	0.000301	0.00113	CcSEcCtD
Etravirine—Body temperature increased—Irinotecan—pancreatic cancer	0.0003	0.00112	CcSEcCtD
Etravirine—Abdominal pain—Irinotecan—pancreatic cancer	0.0003	0.00112	CcSEcCtD
Etravirine—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.0003	0.00112	CcSEcCtD
Etravirine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000299	0.00112	CcSEcCtD
Etravirine—Anaemia—Docetaxel—pancreatic cancer	0.000297	0.00111	CcSEcCtD
Etravirine—Gastritis—Doxorubicin—pancreatic cancer	0.000295	0.0011	CcSEcCtD
Etravirine—Vomiting—Sunitinib—pancreatic cancer	0.000293	0.0011	CcSEcCtD
Etravirine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000292	0.00109	CcSEcCtD
Etravirine—Rash—Sunitinib—pancreatic cancer	0.00029	0.00109	CcSEcCtD
Etravirine—Dermatitis—Sunitinib—pancreatic cancer	0.00029	0.00109	CcSEcCtD
Etravirine—Abdominal distension—Doxorubicin—pancreatic cancer	0.00029	0.00109	CcSEcCtD
Etravirine—Headache—Sunitinib—pancreatic cancer	0.000288	0.00108	CcSEcCtD
Etravirine—Syncope—Docetaxel—pancreatic cancer	0.000288	0.00108	CcSEcCtD
Etravirine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000287	0.00108	CcSEcCtD
Etravirine—Eosinophilia—Doxorubicin—pancreatic cancer	0.000285	0.00107	CcSEcCtD
Etravirine—Loss of consciousness—Docetaxel—pancreatic cancer	0.000282	0.00106	CcSEcCtD
Etravirine—Pancreatitis—Doxorubicin—pancreatic cancer	0.000282	0.00106	CcSEcCtD
Etravirine—Hyperglycaemia—Epirubicin—pancreatic cancer	0.00028	0.00105	CcSEcCtD
Etravirine—Angina pectoris—Doxorubicin—pancreatic cancer	0.00028	0.00105	CcSEcCtD
Etravirine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000279	0.00105	CcSEcCtD
Etravirine—Convulsion—Docetaxel—pancreatic cancer	0.000278	0.00104	CcSEcCtD
Etravirine—Hypertension—Docetaxel—pancreatic cancer	0.000277	0.00104	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000275	0.00103	CcSEcCtD
Etravirine—Nausea—Sunitinib—pancreatic cancer	0.000273	0.00103	CcSEcCtD
Etravirine—Renal failure—Epirubicin—pancreatic cancer	0.000273	0.00102	CcSEcCtD
Etravirine—Asthenia—Irinotecan—pancreatic cancer	0.000272	0.00102	CcSEcCtD
Etravirine—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000272	0.00102	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000272	0.00102	CcSEcCtD
Etravirine—Stomatitis—Epirubicin—pancreatic cancer	0.00027	0.00101	CcSEcCtD
Etravirine—Conjunctivitis—Epirubicin—pancreatic cancer	0.000269	0.00101	CcSEcCtD
Etravirine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000268	0.001	CcSEcCtD
Etravirine—Dry mouth—Docetaxel—pancreatic cancer	0.000267	0.001	CcSEcCtD
Etravirine—Asthenia—Gemcitabine—pancreatic cancer	0.000265	0.000994	CcSEcCtD
Etravirine—Confusional state—Docetaxel—pancreatic cancer	0.000264	0.000991	CcSEcCtD
Etravirine—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000262	0.000983	CcSEcCtD
Etravirine—Infection—Docetaxel—pancreatic cancer	0.00026	0.000976	CcSEcCtD
Etravirine—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.00026	0.000973	CcSEcCtD
Etravirine—Diarrhoea—Irinotecan—pancreatic cancer	0.000259	0.000973	CcSEcCtD
Etravirine—Shock—Docetaxel—pancreatic cancer	0.000258	0.000967	CcSEcCtD
Etravirine—Nervous system disorder—Docetaxel—pancreatic cancer	0.000257	0.000964	CcSEcCtD
Etravirine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000257	0.000962	CcSEcCtD
Etravirine—Skin disorder—Docetaxel—pancreatic cancer	0.000255	0.000955	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000254	0.000954	CcSEcCtD
Etravirine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000253	0.000948	CcSEcCtD
Etravirine—Renal failure—Doxorubicin—pancreatic cancer	0.000252	0.000945	CcSEcCtD
Etravirine—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000251	0.000943	CcSEcCtD
Etravirine—Dizziness—Irinotecan—pancreatic cancer	0.000251	0.00094	CcSEcCtD
Etravirine—Stomatitis—Doxorubicin—pancreatic cancer	0.00025	0.000938	CcSEcCtD
Etravirine—Anorexia—Docetaxel—pancreatic cancer	0.00025	0.000937	CcSEcCtD
Etravirine—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000249	0.000935	CcSEcCtD
Etravirine—Hepatitis—Epirubicin—pancreatic cancer	0.000249	0.000933	CcSEcCtD
Etravirine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000249	0.000932	CcSEcCtD
Etravirine—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000248	0.000928	CcSEcCtD
Etravirine—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000246	0.000922	CcSEcCtD
Etravirine—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000245	0.000917	CcSEcCtD
Etravirine—Urethral disorder—Epirubicin—pancreatic cancer	0.000244	0.000915	CcSEcCtD
Etravirine—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000243	0.00091	CcSEcCtD
Etravirine—Vomiting—Irinotecan—pancreatic cancer	0.000241	0.000904	CcSEcCtD
Etravirine—Dizziness—Fluorouracil—pancreatic cancer	0.00024	0.000901	CcSEcCtD
Etravirine—Rash—Irinotecan—pancreatic cancer	0.000239	0.000897	CcSEcCtD
Etravirine—Dermatitis—Irinotecan—pancreatic cancer	0.000239	0.000896	CcSEcCtD
Etravirine—Headache—Irinotecan—pancreatic cancer	0.000238	0.000891	CcSEcCtD
Etravirine—Insomnia—Docetaxel—pancreatic cancer	0.000237	0.000889	CcSEcCtD
Etravirine—Paraesthesia—Docetaxel—pancreatic cancer	0.000235	0.000883	CcSEcCtD
Etravirine—Erythema multiforme—Epirubicin—pancreatic cancer	0.000235	0.000882	CcSEcCtD
Etravirine—Vomiting—Gemcitabine—pancreatic cancer	0.000235	0.000881	CcSEcCtD
Etravirine—Somnolence—Docetaxel—pancreatic cancer	0.000233	0.000874	CcSEcCtD
Etravirine—Rash—Gemcitabine—pancreatic cancer	0.000233	0.000873	CcSEcCtD
Etravirine—Dermatitis—Gemcitabine—pancreatic cancer	0.000233	0.000872	CcSEcCtD
Etravirine—Eye disorder—Epirubicin—pancreatic cancer	0.000233	0.000872	CcSEcCtD
Etravirine—Headache—Gemcitabine—pancreatic cancer	0.000231	0.000868	CcSEcCtD
Etravirine—Cardiac disorder—Epirubicin—pancreatic cancer	0.000231	0.000866	CcSEcCtD
Etravirine—Vomiting—Fluorouracil—pancreatic cancer	0.000231	0.000866	CcSEcCtD
Etravirine—Hepatitis—Doxorubicin—pancreatic cancer	0.00023	0.000863	CcSEcCtD
Etravirine—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000229	0.000859	CcSEcCtD
Etravirine—Rash—Fluorouracil—pancreatic cancer	0.000229	0.000859	CcSEcCtD
Etravirine—Dermatitis—Fluorouracil—pancreatic cancer	0.000229	0.000858	CcSEcCtD
Etravirine—Decreased appetite—Docetaxel—pancreatic cancer	0.000228	0.000854	CcSEcCtD
Etravirine—Headache—Fluorouracil—pancreatic cancer	0.000228	0.000853	CcSEcCtD
Etravirine—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000227	0.000853	CcSEcCtD
Etravirine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000226	0.000849	CcSEcCtD
Etravirine—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000226	0.000848	CcSEcCtD
Etravirine—Fatigue—Docetaxel—pancreatic cancer	0.000226	0.000847	CcSEcCtD
Etravirine—Angiopathy—Epirubicin—pancreatic cancer	0.000226	0.000847	CcSEcCtD
Etravirine—Urethral disorder—Doxorubicin—pancreatic cancer	0.000226	0.000846	CcSEcCtD
Etravirine—Nausea—Irinotecan—pancreatic cancer	0.000225	0.000845	CcSEcCtD
Etravirine—Immune system disorder—Epirubicin—pancreatic cancer	0.000225	0.000843	CcSEcCtD
Etravirine—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000224	0.000841	CcSEcCtD
Etravirine—Constipation—Docetaxel—pancreatic cancer	0.000224	0.000841	CcSEcCtD
Etravirine—Pain—Docetaxel—pancreatic cancer	0.000224	0.000841	CcSEcCtD
Etravirine—Nausea—Gemcitabine—pancreatic cancer	0.000219	0.000823	CcSEcCtD
Etravirine—Mental disorder—Epirubicin—pancreatic cancer	0.000218	0.000818	CcSEcCtD
Etravirine—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000218	0.000816	CcSEcCtD
Etravirine—Malnutrition—Epirubicin—pancreatic cancer	0.000217	0.000812	CcSEcCtD
Etravirine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000216	0.00081	CcSEcCtD
Etravirine—Nausea—Fluorouracil—pancreatic cancer	0.000216	0.000809	CcSEcCtD
Etravirine—Eye disorder—Doxorubicin—pancreatic cancer	0.000215	0.000807	CcSEcCtD
Etravirine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000214	0.000804	CcSEcCtD
Etravirine—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000214	0.000801	CcSEcCtD
Etravirine—Flatulence—Epirubicin—pancreatic cancer	0.000213	0.0008	CcSEcCtD
Etravirine—Tension—Epirubicin—pancreatic cancer	0.000213	0.000797	CcSEcCtD
Etravirine—Nervousness—Epirubicin—pancreatic cancer	0.00021	0.000789	CcSEcCtD
Etravirine—Angiopathy—Doxorubicin—pancreatic cancer	0.000209	0.000783	CcSEcCtD
Etravirine—Immune system disorder—Doxorubicin—pancreatic cancer	0.000208	0.00078	CcSEcCtD
Etravirine—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000208	0.000778	CcSEcCtD
Etravirine—Abdominal pain—Docetaxel—pancreatic cancer	0.000207	0.000777	CcSEcCtD
Etravirine—Body temperature increased—Docetaxel—pancreatic cancer	0.000207	0.000777	CcSEcCtD
Etravirine—Vision blurred—Epirubicin—pancreatic cancer	0.000204	0.000766	CcSEcCtD
Etravirine—Mental disorder—Doxorubicin—pancreatic cancer	0.000202	0.000756	CcSEcCtD
Etravirine—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000201	0.000754	CcSEcCtD
Etravirine—Malnutrition—Doxorubicin—pancreatic cancer	0.0002	0.000752	CcSEcCtD
Etravirine—Anaemia—Epirubicin—pancreatic cancer	0.0002	0.000751	CcSEcCtD
Etravirine—Flatulence—Doxorubicin—pancreatic cancer	0.000198	0.000741	CcSEcCtD
Etravirine—Tension—Doxorubicin—pancreatic cancer	0.000197	0.000738	CcSEcCtD
Etravirine—Malaise—Epirubicin—pancreatic cancer	0.000195	0.000733	CcSEcCtD
Etravirine—Nervousness—Doxorubicin—pancreatic cancer	0.000195	0.00073	CcSEcCtD
Etravirine—Vertigo—Epirubicin—pancreatic cancer	0.000195	0.00073	CcSEcCtD
Etravirine—Syncope—Epirubicin—pancreatic cancer	0.000194	0.000728	CcSEcCtD
Etravirine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000193	0.000724	CcSEcCtD
Etravirine—Loss of consciousness—Epirubicin—pancreatic cancer	0.00019	0.000714	CcSEcCtD
Etravirine—Vision blurred—Doxorubicin—pancreatic cancer	0.000189	0.000708	CcSEcCtD
Etravirine—Asthenia—Docetaxel—pancreatic cancer	0.000188	0.000705	CcSEcCtD
Etravirine—Convulsion—Epirubicin—pancreatic cancer	0.000188	0.000704	CcSEcCtD
Etravirine—Hypertension—Epirubicin—pancreatic cancer	0.000187	0.000701	CcSEcCtD
Etravirine—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000186	0.000697	CcSEcCtD
Etravirine—Anaemia—Doxorubicin—pancreatic cancer	0.000185	0.000695	CcSEcCtD
Etravirine—Anxiety—Epirubicin—pancreatic cancer	0.000184	0.000689	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000183	0.000687	CcSEcCtD
Etravirine—Discomfort—Epirubicin—pancreatic cancer	0.000182	0.000683	CcSEcCtD
Etravirine—Malaise—Doxorubicin—pancreatic cancer	0.000181	0.000678	CcSEcCtD
Etravirine—Dry mouth—Epirubicin—pancreatic cancer	0.00018	0.000676	CcSEcCtD
Etravirine—Vertigo—Doxorubicin—pancreatic cancer	0.00018	0.000675	CcSEcCtD
Etravirine—Syncope—Doxorubicin—pancreatic cancer	0.00018	0.000674	CcSEcCtD
Etravirine—Diarrhoea—Docetaxel—pancreatic cancer	0.000179	0.000673	CcSEcCtD
Etravirine—Confusional state—Epirubicin—pancreatic cancer	0.000178	0.000668	CcSEcCtD
Etravirine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000176	0.000661	CcSEcCtD
Etravirine—Infection—Epirubicin—pancreatic cancer	0.000176	0.000659	CcSEcCtD
Etravirine—Shock—Epirubicin—pancreatic cancer	0.000174	0.000652	CcSEcCtD
Etravirine—Convulsion—Doxorubicin—pancreatic cancer	0.000174	0.000651	CcSEcCtD
Etravirine—Nervous system disorder—Epirubicin—pancreatic cancer	0.000173	0.00065	CcSEcCtD
Etravirine—Dizziness—Docetaxel—pancreatic cancer	0.000173	0.00065	CcSEcCtD
Etravirine—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000173	0.000649	CcSEcCtD
Etravirine—Hypertension—Doxorubicin—pancreatic cancer	0.000173	0.000649	CcSEcCtD
Etravirine—Skin disorder—Epirubicin—pancreatic cancer	0.000172	0.000644	CcSEcCtD
Etravirine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000171	0.000641	CcSEcCtD
Etravirine—Anxiety—Doxorubicin—pancreatic cancer	0.00017	0.000638	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000169	0.000635	CcSEcCtD
Etravirine—Discomfort—Doxorubicin—pancreatic cancer	0.000169	0.000632	CcSEcCtD
Etravirine—Anorexia—Epirubicin—pancreatic cancer	0.000169	0.000632	CcSEcCtD
Etravirine—Dry mouth—Doxorubicin—pancreatic cancer	0.000167	0.000626	CcSEcCtD
Etravirine—Vomiting—Docetaxel—pancreatic cancer	0.000167	0.000625	CcSEcCtD
Etravirine—Rash—Docetaxel—pancreatic cancer	0.000165	0.00062	CcSEcCtD
Etravirine—Dermatitis—Docetaxel—pancreatic cancer	0.000165	0.000619	CcSEcCtD
Etravirine—Confusional state—Doxorubicin—pancreatic cancer	0.000165	0.000619	CcSEcCtD
Etravirine—Headache—Docetaxel—pancreatic cancer	0.000164	0.000616	CcSEcCtD
Etravirine—Infection—Doxorubicin—pancreatic cancer	0.000163	0.000609	CcSEcCtD
Etravirine—Shock—Doxorubicin—pancreatic cancer	0.000161	0.000604	CcSEcCtD
Etravirine—Nervous system disorder—Doxorubicin—pancreatic cancer	0.00016	0.000602	CcSEcCtD
Etravirine—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.00016	0.000601	CcSEcCtD
Etravirine—Insomnia—Epirubicin—pancreatic cancer	0.00016	0.0006	CcSEcCtD
Etravirine—Skin disorder—Doxorubicin—pancreatic cancer	0.000159	0.000596	CcSEcCtD
Etravirine—Paraesthesia—Epirubicin—pancreatic cancer	0.000159	0.000595	CcSEcCtD
Etravirine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000158	0.000593	CcSEcCtD
Etravirine—Somnolence—Epirubicin—pancreatic cancer	0.000157	0.000589	CcSEcCtD
Etravirine—Anorexia—Doxorubicin—pancreatic cancer	0.000156	0.000585	CcSEcCtD
Etravirine—Nausea—Docetaxel—pancreatic cancer	0.000156	0.000584	CcSEcCtD
Etravirine—Decreased appetite—Epirubicin—pancreatic cancer	0.000154	0.000576	CcSEcCtD
Etravirine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000153	0.000572	CcSEcCtD
Etravirine—Fatigue—Epirubicin—pancreatic cancer	0.000152	0.000572	CcSEcCtD
Etravirine—Pain—Epirubicin—pancreatic cancer	0.000151	0.000567	CcSEcCtD
Etravirine—Constipation—Epirubicin—pancreatic cancer	0.000151	0.000567	CcSEcCtD
Etravirine—Insomnia—Doxorubicin—pancreatic cancer	0.000148	0.000555	CcSEcCtD
Etravirine—Paraesthesia—Doxorubicin—pancreatic cancer	0.000147	0.000551	CcSEcCtD
Etravirine—Feeling abnormal—Epirubicin—pancreatic cancer	0.000146	0.000546	CcSEcCtD
Etravirine—Somnolence—Doxorubicin—pancreatic cancer	0.000145	0.000545	CcSEcCtD
Etravirine—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000145	0.000542	CcSEcCtD
Etravirine—Decreased appetite—Doxorubicin—pancreatic cancer	0.000142	0.000533	CcSEcCtD
Etravirine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000141	0.00053	CcSEcCtD
Etravirine—Fatigue—Doxorubicin—pancreatic cancer	0.000141	0.000529	CcSEcCtD
Etravirine—Pain—Doxorubicin—pancreatic cancer	0.00014	0.000525	CcSEcCtD
Etravirine—Constipation—Doxorubicin—pancreatic cancer	0.00014	0.000525	CcSEcCtD
Etravirine—Abdominal pain—Epirubicin—pancreatic cancer	0.00014	0.000524	CcSEcCtD
Etravirine—Body temperature increased—Epirubicin—pancreatic cancer	0.00014	0.000524	CcSEcCtD
Etravirine—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000135	0.000505	CcSEcCtD
Etravirine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000134	0.000502	CcSEcCtD
Etravirine—Hypersensitivity—Epirubicin—pancreatic cancer	0.00013	0.000488	CcSEcCtD
Etravirine—Body temperature increased—Doxorubicin—pancreatic cancer	0.000129	0.000485	CcSEcCtD
Etravirine—Abdominal pain—Doxorubicin—pancreatic cancer	0.000129	0.000485	CcSEcCtD
Etravirine—Asthenia—Epirubicin—pancreatic cancer	0.000127	0.000476	CcSEcCtD
Etravirine—Diarrhoea—Epirubicin—pancreatic cancer	0.000121	0.000454	CcSEcCtD
Etravirine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000121	0.000452	CcSEcCtD
Etravirine—Asthenia—Doxorubicin—pancreatic cancer	0.000117	0.00044	CcSEcCtD
Etravirine—Dizziness—Epirubicin—pancreatic cancer	0.000117	0.000438	CcSEcCtD
Etravirine—Vomiting—Epirubicin—pancreatic cancer	0.000112	0.000422	CcSEcCtD
Etravirine—Diarrhoea—Doxorubicin—pancreatic cancer	0.000112	0.00042	CcSEcCtD
Etravirine—Rash—Epirubicin—pancreatic cancer	0.000111	0.000418	CcSEcCtD
Etravirine—Dermatitis—Epirubicin—pancreatic cancer	0.000111	0.000418	CcSEcCtD
Etravirine—Headache—Epirubicin—pancreatic cancer	0.000111	0.000415	CcSEcCtD
Etravirine—Dizziness—Doxorubicin—pancreatic cancer	0.000108	0.000406	CcSEcCtD
Etravirine—Nausea—Epirubicin—pancreatic cancer	0.000105	0.000394	CcSEcCtD
Etravirine—Vomiting—Doxorubicin—pancreatic cancer	0.000104	0.00039	CcSEcCtD
Etravirine—Rash—Doxorubicin—pancreatic cancer	0.000103	0.000387	CcSEcCtD
Etravirine—Dermatitis—Doxorubicin—pancreatic cancer	0.000103	0.000386	CcSEcCtD
Etravirine—Headache—Doxorubicin—pancreatic cancer	0.000102	0.000384	CcSEcCtD
Etravirine—Nausea—Doxorubicin—pancreatic cancer	9.72e-05	0.000364	CcSEcCtD
